Anti-neoangiogenic nanodelivery systems: advances in tumor-based and ophthalmic disease research
Journal of Materials Chemistry B · 2025 · 13 (42) · 13527-13566
DOI: 10.1039/d5tb01502b ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Materials Chemistry B, 2025. Verfasst von Bingjie Guo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Inner Mongolia Medical University, No. 5, Xinhua Road, Hohhot, Inner Mongolia 010059, China. 17771564957@163.com. Hauptthemen laut MEDLINE: Angiogenesis Inhibitors, Neoplasms, Neovascularization, Pathologic, Eye Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 263 Literaturangaben.
Abstract (Originalsprache)
Nanoplatform-based strategies for anti-angiogenic therapy are discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Inner Mongolia Medical University, No. 5, Xinhua Road, Hohhot, Inner Mongolia 010059, China. 17771564957@163.com.
- Shanghai Wei Er Lab, Shanghai 201707, China. weisty_0324@163.com.
Zitieren
APA
Guo, B., Li, Z., Zhou, J., Shu, R., Wei, W., Kuang, Y., Xu, Y., & Wu, X. (2025). Anti-neoangiogenic nanodelivery systems: advances in tumor-based and ophthalmic disease research. Journal of Materials Chemistry B, 13(42), 13527-13566. https://doi.org/10.1039/d5tb01502b
Vancouver
Guo B, Li Z, Zhou J, Shu R, Wei W, Kuang Y, et al. Anti-neoangiogenic nanodelivery systems: advances in tumor-based and ophthalmic disease research. Journal of Materials Chemistry B. 2025;13(42):13527-13566. doi:10.1039/d5tb01502b
BibTeX
@article{Guo2025,
author = {Guo, Bingjie and Li, Zhaokai and Zhou, Junyi and Shu, Ruobei and Wei, Wuhao and Kuang, Yanting and Xu, Youfa and Wu, Xin},
title = {Anti-neoangiogenic nanodelivery systems: advances in tumor-based and ophthalmic disease research},
journal = {Journal of Materials Chemistry B},
year = {2025},
volume = {13},
number = {42},
pages = {13527--13566},
doi = {10.1039/d5tb01502b}
}
EUVIMED